These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2570858)

  • 21. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR; Minaian A
    Gen Pharmacol; 1991; 22(6):1017-21. PubMed ID: 1687391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.
    Andén NE; Grabowska-Andén M
    J Neural Transm Gen Sect; 1990; 79(3):209-14. PubMed ID: 2136999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of central D1 dopamine receptors reverses reserpine-induced hypothermia in mice.
    Duterte-Boucher D; Panissaud C; Michael-Titus A; Costentin J
    Neuropharmacology; 1989 Apr; 28(4):419-21. PubMed ID: 2568597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR; Tabatabai SA
    Psychopharmacology (Berl); 1992; 107(2-3):341-6. PubMed ID: 1535446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locomotor behaviour of selective dopamine agonists in mice: is endogenous dopamine the only catecholamine involved?
    Pichler L; Pifl C
    J Pharm Pharmacol; 1989 Oct; 41(10):690-3. PubMed ID: 2575146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
    Sharma A; Kulkarni SK
    Indian J Exp Biol; 1994 Mar; 32(3):176-9. PubMed ID: 8070837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain.
    Hörtnagl H; Pichler L; Holzer-Petsche U; Hornykiewicz O; Kobinger W
    Eur J Pharmacol; 1984 Nov; 106(2):335-44. PubMed ID: 6152218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1993 Apr; 234(2-3):155-63. PubMed ID: 8097720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of D1 receptor stimulation in normal and MPTP monkeys.
    Bédard PJ; Boucher R
    Neurosci Lett; 1989 Sep; 104(1-2):223-8. PubMed ID: 2573015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
    Verma A; Kulkarni SK; Nayar U
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.